效力
体内
药代动力学
药理学
归巢(生物学)
药效学
体外
化学
受体
生物
生物化学
生态学
生物技术
作者
Naresh Singh Redhu,Ali Hussain,Sathish Srinivasan,Dooyoung Lee,Brianna Bannister,Natalia Blanco,Raegan Bonesteel,Adam J. Camblin,Laura Cappellucci,Rhianna Cohen,Bryce A. Harrison,Kris Hahn,Kwangsoo Kim,Megan T. Krumpoch,Fu‐Yang Lin,Kevin McManus,Molly A. McShea,Jessica R. Pondish,Peter Linde,Alex Lugovskoy
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:2021-05-01
卷期号:206 (1_Supplement): 11.15-11.15
标识
DOI:10.4049/jimmunol.206.supp.11.15
摘要
Abstract Objective MORF-057 is an orally bioavailable, selective, and potent small molecule inhibitor of α4β7 integrin being developed for inflammatory bowel diseases (IBD) that is currently in phase 1 clinical testing. We have previously presented work that characterized its nonclinical pharmacologic profile. The current study integrates data to generate a pharmacokinetic (PK) and pharmacodynamic (PD) model of MORF-057. Methods To determine in vivo potency, MORF-057 was tested in murine gut homing assays and the PD response was determined relative to the non-protein bound drug in mouse plasma. A cell adhesion assay (CAA) for α4β7 was refined to enable detection of picomolar-level sensitivity. Murine receptor occupancy (RO) assays for α4β7 and α4β1 were established under physiologic conditions, and MORF-057 was evaluated for its potency and selectivity in fresh mouse whole blood. These datasets were used to build and validate predictive models of PD response. Results MORF-057 strongly inhibited the homing of α4β7hi cells to murine gut lymphoid tissues with an IC90 of 7.9 nM. MORF-057 showed high potency in CAA with an IC90 of 8.8 nM. Similarly, RO assays confirmed MORF-057 to be a highly potent inhibitor of α4β7 in mouse whole blood with an IC90 of 20.5 nM and over 1500-fold selectivity vs. α4β1. The predictive models built upon these datasets revealed a strong PK-PD relationship of α4β7 inhibitors in vivo. Conclusions We observed consistently high potency of MORF-057 across multiple assay platforms. Integrated modeling based on these assays, particularly the RO assay, successfully predicted the PD response to MORF-057. These data begin to establish the relationship between PK, target engagement, and PD with MORF-057.
科研通智能强力驱动
Strongly Powered by AbleSci AI